Related Experiment Video

Updated: Apr 23, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

707

Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity

Michael Kaplan1, Ruben Bromiker1, Cathy Hammerman1

  • 1Department of Neonatology, Shaare Zedek Medical Center, PO Box 3235, Jerusalem 91031, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel.

Seminars in Perinatology
|October 7, 2014
PubMed

Insights

Severe hemolysis amplifies the risk of brain damage in newborns with high bilirubin levels. Identifying babies with increased hemolysis is crucial for enhanced monitoring and preventing bilirubin neurotoxicity.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Hematology

Background:

  • Severe neonatal hyperbilirubinemia poses a risk of bilirubin neurotoxicity.
  • Hemolysis, the breakdown of red blood cells, may exacerbate this risk.
  • The precise mechanisms linking hemolysis and neurotoxicity remain unclear.

Purpose of the Study:

  • To review the synergistic role of hemolysis and severe hyperbilirubinemia in potentiating bilirubin-induced neurotoxicity.
  • To explore the mechanisms by which hemolysis might increase neurotoxicity risk.
  • To suggest methods for identifying at-risk infants with increased hemolysis.

Main Methods:

  • Literature review of studies investigating hemolysis and neonatal hyperbilirubinemia.
  • Analysis of existing data on bilirubin thresholds for neurotoxicity in different hemolytic conditions.
  • Discussion of potential pathophysiological pathways.

Main Results:

  • Hemolysis appears to lower the bilirubin threshold for neurotoxicity, particularly in direct antiglobulin titer (DAT) positive isoimmune hemolytic disease.
  • Hemolysis may facilitate the development of extremely high serum bilirubin levels.
  • The independent effect of hemolysis versus rapid bilirubin rise on blood-brain barrier penetration is uncertain.

Conclusions:

  • Hemolysis plays a synergistic role in severe neonatal hyperbilirubinemia, increasing the risk of bilirubin neurotoxicity.
  • Further research is needed to elucidate the exact mechanisms.
  • Identifying infants with increased hemolysis is vital for targeted surveillance and intervention.

Keywords:
BilirubinBilirubin neurotoxicityDAT-positive hemolytic diseaseEnd tidal carbon monoxideHemolysisKernicterus

More Related Videos

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.0K
Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

25.2K

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
23
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
20
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
219
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
228